Arthur J. Higgins

2019 - DepoMed

In 2019, Arthur J. Higgins earned a total compensation of $4.9M as President and Chief Executive Officer at DepoMed, a 2% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$793,040
Salary$800,000
Stock Awards$3,267,209
Other$9,120
Total$4,869,369

Higgins received $3.3M in stock awards, accounting for 67% of the total pay in 2019.

Higgins also received $793K in non-equity incentive plan, $800K in salary and $9.1K in other compensation.

Rankings

In 2019, Arthur J. Higgins' compensation ranked 2,294th out of 13,971 executives tracked by ExecPay. In other words, Higgins earned more than 83.6% of executives.

ClassificationRankingPercentile
All
2,294
out of 13,971
84th
Division
Manufacturing
828
out of 5,695
86th
Major group
Chemicals And Allied Products
264
out of 2,194
88th
Industry group
Drugs
212
out of 1,880
89th
Industry
Pharmaceutical Preparations
155
out of 1,392
89th
Source: SEC filing on April 20, 2020.

Higgins' colleagues

We found two more compensation records of executives who worked with Arthur J. Higgins at DepoMed in 2019.

2019

Stanley Bukofzer

DepoMed

Senior Vice President and Chief Scientific and Technical Officer

2019

Daniel Peisert

DepoMed

Chief Financial Officer

News

You may also like